SAN MATEO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company …
SAN MATEO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company …
In